Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Horsman, Michael Robert"'
Autor:
Wittenborn, Thomas Rea, Nielsen, Thomas, Thomsen, Jesper Skovhus, Horsman, Michael Robert, Nygaard, Jens Vinge
Publikováno v:
In Microvascular Research November 2016 108:69-74
Autor:
Busk, Morten, Walenta, Stefan, Mueller-Klieser, Wolfgang, Steiniche, Torben, Jakobsen, Steen, Horsman, Michael Robert, Overgaard, Jens
Publikováno v:
In Radiotherapy and Oncology June 2011 99(3):404-411
Autor:
Horsman, Michael Robert, Brown, J. Martin, van der Kogel, Albert J., Wouters, B.G., Overgaard, Jens
Publikováno v:
Horsman, M R, Brown, J M, van der Kogel, A J, Wouters, B G & Overgaard, J 2019, The oxygen effect and therapeutic approaches to tumour hypoxia . in A J Van der Kogel & M C Joiner (eds), Basic clinical radiobiology . 5 edn, CRC Press, Boca Raton, pp. 188-205 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::3a6cdaaa66b677080a6dcca358cb568c
https://pure.au.dk/portal/da/publications/the-oxygen-effect-and-therapeutic-approaches-to-tumour-hypoxia(40e50248-de9d-48e2-9033-0f7c8707e9f4).html
https://pure.au.dk/portal/da/publications/the-oxygen-effect-and-therapeutic-approaches-to-tumour-hypoxia(40e50248-de9d-48e2-9033-0f7c8707e9f4).html
Publikováno v:
Horsman, M R & Siemann, D W 2017, Vascular targeting agents . in M Schwaub (ed.), Encyclopedia of Cancer . 4 edn, Springer, Berlin, Tyskland, pp. 3897-3900 . https://doi.org/10.1007/978-3-642-16483-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::56da62ad3e3cac6778f0b6a09aad7a2b
https://pure.au.dk/portal/da/publications/vascular-targeting-agents(0118cf73-1ca2-4f57-8452-1c70e8bbee07).html
https://pure.au.dk/portal/da/publications/vascular-targeting-agents(0118cf73-1ca2-4f57-8452-1c70e8bbee07).html
Publikováno v:
de Almeida Campos, R C, Horsman, M R & Ferapontova, E 2014, ' Electrochemical analysis of miRNA deregulated during the hypoxia conditions ' 12th Topical Meeting of the International Society of Electrochemistry. Bioelectrochemistry 2013., Bochum, Germany, 17/03/2013-21/03/2013, .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::890481fa215423770e83ec77cb1638c3
https://pure.au.dk/portal/da/publications/electrochemical-analysis-of-mirna-deregulated-during-the-hypoxia-conditions(e52daebe-09d9-4062-97fe-4ec54c28440e).html
https://pure.au.dk/portal/da/publications/electrochemical-analysis-of-mirna-deregulated-during-the-hypoxia-conditions(e52daebe-09d9-4062-97fe-4ec54c28440e).html
Publikováno v:
Siemann, D W, Dai, Y & Horsman, M R 2014, Hypoxia, Metastasis, and Antiangiogenic Therapies . in G Melilo (ed.), Hypoxia and Cancer : Biological Implications and Therapeutic Opportunities . Humana Press, New York, Cancer Drug Discovery and Development, pp. 205-228 . < http://www.springer.com/biomed/cancer/book/978-1-4614-9166-8 >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::3218f24e8afb74e125506d24e00fc7b8
https://pure.au.dk/portal/da/publications/hypoxia-metastasis-and-antiangiogenic-therapies(254aa2fd-c69c-4865-ad12-d177d259f647).html
https://pure.au.dk/portal/da/publications/hypoxia-metastasis-and-antiangiogenic-therapies(254aa2fd-c69c-4865-ad12-d177d259f647).html
Publikováno v:
Horsman, M R, Christensen, K L & Overgaard, J 2013, ' Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo ', International Journal of Hyperthermia, vol. 5, no. 2, pp. 123-36 . https://doi.org/10.3109/02656738909140442
Prolonged oxygen deprivation of cells in vitro or in vivo increases the sensitivity of those cells to heat. Hydralazine is a peripheral vasodilator, currently used clinically as an antihypertensive agent, which has been reported to be able to reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::9b3ff69fe47ae8b0dd3eb01032d1043f
https://pure.au.dk/portal/da/publications/hydralazineinduced-enhancement-of-hyperthermic-damage-in-a-c3h-mammary-carcinoma-in-vivo(c306ebb9-12f9-46f9-8009-7f31421d9381).html
https://pure.au.dk/portal/da/publications/hydralazineinduced-enhancement-of-hyperthermic-damage-in-a-c3h-mammary-carcinoma-in-vivo(c306ebb9-12f9-46f9-8009-7f31421d9381).html
Publikováno v:
Osinsky, S, Molls, M, Horsman, M R & Vaupel, P 2011, Tumour hypoxia in the clinical setting: Conclusions . in S Osinsky, H Friess & P Vaupel (eds), Tumor hypoxia in the clinical setting . National Academy of Sciences Ukraine, Kyiv Akademperiodyka, Kiev, pp. 265-268 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::8600649c3459dc18ce69f60e86ce3488
https://pure.au.dk/portal/da/publications/tumour-hypoxia-in-the-clinical-setting-conclusions(f23fab32-b4e1-45ba-ada0-1c34d00dd9ec).html
https://pure.au.dk/portal/da/publications/tumour-hypoxia-in-the-clinical-setting-conclusions(f23fab32-b4e1-45ba-ada0-1c34d00dd9ec).html
Autor:
Horsman, Michael Robert, Vaupel, Peter
Publikováno v:
Horsman, M R & Vaupel, P 2011, Tumor hypoxia and the response to therapy . in S Osinsky, H Friess & P Vaupel (eds), Tumor hypoxia in the clinical setting . National Academy of Sciences Ukraine, Kyiv Akademperiodyka, Kiev, pp. 69-92 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::50abc2a0c0d94b0b11641b53914581c8
https://pure.au.dk/portal/da/publications/tumor-hypoxia-and-the-response-to-therapy(077a542e-cf10-44eb-9237-f5b7fbe4e9bc).html
https://pure.au.dk/portal/da/publications/tumor-hypoxia-and-the-response-to-therapy(077a542e-cf10-44eb-9237-f5b7fbe4e9bc).html
Autor:
Hasselbalch, Benedikte, Eriksen, Jesper Grau, Broholm, Helle, Christensen, Ib Jarle, Grunnet, Kirsten, Horsman, Michael Robert, Poulsen, Hans Skovgaard, Stockhausen, Marie-Thérése, Lassen, Ulrik V
Publikováno v:
Hasselbalch, B, Eriksen, J G, Broholm, H, Christensen, I J, Grunnet, K, Horsman, M R, Poulsen, H S, Stockhausen, M-T & Lassen, U 2010, ' Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan ', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 118, no. 8, pp. 585-94 . https://doi.org/10.1111/j.1600-0463.2010.02631.x
Hasselbalch, B, Eriksen, J G, Broholm, H, Christensen, I J, Grunnet, K, Horsman, M R, Poulsen, H S, Stockhausen, M-T & Lassen, U V 2010, ' Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan ', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 118, no. 8, pp. 585-94 . https://doi.org/10.1111/j.1600-0463.2010.02631.x
Hasselbalch, B, Eriksen, J G, Broholm, H, Christensen, I J, Grunnet, K, Horsman, M R, Poulsen, H S, Stockhausen, M-T & Lassen, U V 2010, ' Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan ', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 118, no. 8, pp. 585-94 . https://doi.org/10.1111/j.1600-0463.2010.02631.x
Several recent studies have demonstrated a beneficial effect of anti-angiogenic treatment with the vascular endothelial growth factor-neutralizing antibody bevacizumab in recurrent high-grade glioma. In the current study, immunohistochemical evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2265492795951b209e9e3daa1263b4ab
https://pure.au.dk/portal/da/publications/prospective-evaluation-of-angiogenic-hypoxic-and-egfrrelated-biomarkers-in-recurrent-glioblastoma-multiforme-treated-with-cetuximab-bevacizumab-and-irinotecan(7e037243-138c-4fa2-8e40-2c4b77e378c2).html
https://pure.au.dk/portal/da/publications/prospective-evaluation-of-angiogenic-hypoxic-and-egfrrelated-biomarkers-in-recurrent-glioblastoma-multiforme-treated-with-cetuximab-bevacizumab-and-irinotecan(7e037243-138c-4fa2-8e40-2c4b77e378c2).html